Bulk Manufacturer of Controlled Substances Application: American Radiolabeled Chem, 28664 [2018-13231]
Download as PDF
<![CDATA[
28664
Federal Register / Vol. 83, No. 119 / Wednesday, June 20, 2018 / Notices
Written comments should
be sent to: Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/DRW, 8701
Morrissette Drive, Springfield, Virginia
22152.
ADDRESSES:
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA–392]
Bulk Manufacturer of Controlled
Substances Application: American
Radiolabeled Chem
ACTION:
Notice of application.
Registered bulk manufacturers of
the affected basic classes, and
applicants therefore, may file written
comments on or objections to the
issuance of the proposed registration on
or before August 20, 2018.
DATES:
The
Attorney General has delegated his
authority under the Controlled
Substances Act to the Administrator of
the Drug Enforcement Administration
(DEA), 28 CFR 0.100(b). Authority to
exercise all necessary functions with
respect to the promulgation and
implementation of 21 CFR part 1301,
incident to the registration of
SUPPLEMENTARY INFORMATION:
manufacturers, distributors, dispensers,
importers, and exporters of controlled
substances (other than final orders in
connection with suspension, denial, or
revocation of registration) has been
redelegated to the Assistant
Administrator of the DEA Diversion
Control Division (‘‘Assistant
Administrator’’) pursuant to section 7 of
28 CFR part 0, appendix to subpart R.
In accordance with 21 CFR
1301.33(a), this is notice that on March
13, 2018, American Radiolabeled Chem,
101 Arc Drive, St. Louis, MO 63146
applied to be registered as a bulk
manufacturer of the following basic
classes of controlled substances:
Controlled substance
Drug code
Gamma Hydroxybutyric Acid ...................................................................................................................................
Ibogaine ...................................................................................................................................................................
Lysergic acid diethylamide ......................................................................................................................................
Tetrahydrocannabinols ............................................................................................................................................
Dimethyltryptamine ..................................................................................................................................................
1-[1-(2-Thienyl)cyclohexyl]piperidine .......................................................................................................................
Dihydromorphine ......................................................................................................................................................
Heroin ......................................................................................................................................................................
Normorphine ............................................................................................................................................................
Amphetamine ...........................................................................................................................................................
Methamphetamine ...................................................................................................................................................
Amobarbital ..............................................................................................................................................................
Phencyclidine ...........................................................................................................................................................
Phenylacetone .........................................................................................................................................................
Cocaine ....................................................................................................................................................................
Codeine ....................................................................................................................................................................
Dihydrocodeine ........................................................................................................................................................
Oxycodone ...............................................................................................................................................................
Hydromorphone .......................................................................................................................................................
Ecgonine ..................................................................................................................................................................
Hydrocodone ............................................................................................................................................................
Meperidine ...............................................................................................................................................................
Metazocine ...............................................................................................................................................................
Methadone ...............................................................................................................................................................
Dextropropoxyphene, bulk (non-dosage forms) ......................................................................................................
Morphine ..................................................................................................................................................................
Oripavine ..................................................................................................................................................................
Thebaine ..................................................................................................................................................................
Oxymorphone ..........................................................................................................................................................
Phenazocine ............................................................................................................................................................
Carfentanil ................................................................................................................................................................
Fentanyl ...................................................................................................................................................................
The company plans to manufacture
small quantities of the above-listed
controlled substances as radiolabeled
compounds for biochemical research.
Dated: June 12, 2018.
John J. Martin,
Assistant Administrator.
sradovich on DSK3GMQ082PROD with NOTICES
[FR Doc. 2018–13231 Filed 6–19–18; 8:45 am]
BILLING CODE 4410–09–P
Drug Enforcement Administration
[Docket No. DEA–392]
Bulk Manufacturer of Controlled
Substances Application: Cerilliant
Corporation
Notice of application.
Registered bulk manufacturers of
the affected basic classes, and
applicants therefore, may file written
comments on or objections to the
issuance of the proposed registration on
or before August 20, 2018.
DATES:
VerDate Sep<11>2014
17:58 Jun 19, 2018
Jkt 244001
PO 00000
Frm 00058
Fmt 4703
Sfmt 4703
I
I
I
I
I
I
I
I
I
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
Written comments should
be sent to: Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/DRW, 8701
Morrissette Drive, Springfield, Virginia
22152.
ADDRESSES:
DEPARTMENT OF JUSTICE
ACTION:
2010
7260
7315
7370
7435
7470
9145
9200
9313
1100
1105
2125
7471
8501
9041
9050
9120
9143
9150
9180
9193
9230
9240
9250
9273
9300
9330
9333
9652
9715
9743
9801
Schedule
The
Attorney General has delegated his
authority under the Controlled
Substances Act to the Administrator of
the Drug Enforcement Administration
(DEA), 28 CFR 0.100(b). Authority to
exercise all necessary functions with
respect to the promulgation and
implementation of 21 CFR part 1301,
incident to the registration of
manufacturers, distributors, dispensers,
SUPPLEMENTARY INFORMATION:
E:\FR\FM\20JNN1.SGM
20JNN1
]]>Agencies
[Federal Register Volume 83, Number 119 (Wednesday, June 20, 2018)]
[Notices]
[Page 28664]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2018-13231]
[[Page 28664]]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA-392]
Bulk Manufacturer of Controlled Substances Application: American
Radiolabeled Chem
ACTION: Notice of application.
-----------------------------------------------------------------------
DATES: Registered bulk manufacturers of the affected basic classes, and
applicants therefore, may file written comments on or objections to the
issuance of the proposed registration on or before August 20, 2018.
ADDRESSES: Written comments should be sent to: Drug Enforcement
Administration, Attention: DEA Federal Register Representative/DRW,
8701 Morrissette Drive, Springfield, Virginia 22152.
SUPPLEMENTARY INFORMATION: The Attorney General has delegated his
authority under the Controlled Substances Act to the Administrator of
the Drug Enforcement Administration (DEA), 28 CFR 0.100(b). Authority
to exercise all necessary functions with respect to the promulgation
and implementation of 21 CFR part 1301, incident to the registration of
manufacturers, distributors, dispensers, importers, and exporters of
controlled substances (other than final orders in connection with
suspension, denial, or revocation of registration) has been redelegated
to the Assistant Administrator of the DEA Diversion Control Division
(``Assistant Administrator'') pursuant to section 7 of 28 CFR part 0,
appendix to subpart R.
In accordance with 21 CFR 1301.33(a), this is notice that on March
13, 2018, American Radiolabeled Chem, 101 Arc Drive, St. Louis, MO
63146 applied to be registered as a bulk manufacturer of the following
basic classes of controlled substances:
------------------------------------------------------------------------
Controlled substance Drug code Schedule
------------------------------------------------------------------------
Gamma Hydroxybutyric Acid............... 2010 I
Ibogaine................................ 7260 I
Lysergic acid diethylamide.............. 7315 I
Tetrahydrocannabinols................... 7370 I
Dimethyltryptamine...................... 7435 I
1-[1-(2-Thienyl)cyclohexyl]piperidine... 7470 I
Dihydromorphine......................... 9145 I
Heroin.................................. 9200 I
Normorphine............................. 9313 I
Amphetamine............................. 1100 II
Methamphetamine......................... 1105 II
Amobarbital............................. 2125 II
Phencyclidine........................... 7471 II
Phenylacetone........................... 8501 II
Cocaine................................. 9041 II
Codeine................................. 9050 II
Dihydrocodeine.......................... 9120 II
Oxycodone............................... 9143 II
Hydromorphone........................... 9150 II
Ecgonine................................ 9180 II
Hydrocodone............................. 9193 II
Meperidine.............................. 9230 II
Metazocine.............................. 9240 II
Methadone............................... 9250 II
Dextropropoxyphene, bulk (non-dosage 9273 II
forms).................................
Morphine................................ 9300 II
Oripavine............................... 9330 II
Thebaine................................ 9333 II
Oxymorphone............................. 9652 II
Phenazocine............................. 9715 II
Carfentanil............................. 9743 II
Fentanyl................................ 9801 II
------------------------------------------------------------------------
The company plans to manufacture small quantities of the above-
listed controlled substances as radiolabeled compounds for biochemical
research.
Dated: June 12, 2018.
John J. Martin,
Assistant Administrator.
[FR Doc. 2018-13231 Filed 6-19-18; 8:45 am]
BILLING CODE 4410-09-P
